Publications

5891 Results

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors
JS Macdonald;SR Smalley;J Benedetti;SA Hundahl;NC Estes;GN Stemmermann;DG Haller;JA Ajani;LL Gunderson;JM Jessup;JA Martenson
Journal / Conference
New England Journal of Medicine 345(10):725-730
Year
2001
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Consolidation docetaxel following concurrent chemoradiotherapy in pathologic stage IIIb non-small cell lung cancer (NSCLC) (SWOG 9504): patterns of failure and updated survival

Authors
LE Gaspar;DR Gandara;K Chansky;KS Albain;PN Lara Jr;JJ Crowley;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 20:315a(#1255)
Year
2001
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

E-Cadherin, a and b-catenins in gastric cancer expression

Authors
OJ Kim;G Stemmermann;G DeVoe;A Noffsinger;J Macdonald;C Fenoglio-Preiser
Journal / Conference
Modern Pathology 14:88A(#506)
Year
2001
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

SWOG 8710 (INT-0080): randomized phase III trial of neoadjuvant MVAC + cystectomy versus cystectomy alone in patients with locally advanced bladder cancer

Authors
RB Natale;HB Grossman;B Blumenstein;N Vogelzang;DL Trump;VO Speights;R deVere White;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 20:2a(#3)
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Does a prior radical prostatectomy (RP) alter outcome of hormonal therapy for metastatic (M+) prostate cancer (CAP)

Authors
IM Thompson;J Basler;C Tangen;ED Crawford
Journal / Conference
Journal of Urology 165(5)Suppl:168(#689)
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Nephrectomy followed by interferon alfa 2-b compared with interferon alfa-2b alone for metastatic renal-cell cancer

Authors
RC Flanigan;SE Salmon;BA Blumenstein;SI Bearman;V Roy;PC McGrath;JR Caton, Jr;N Munshi;ED Crawford
Journal / Conference
New England Journal of Medicine 345(23):1655-1659
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949

Molecular epidemiologic studies within the selenium and vitamin E cancer prevention trial (SELECT)

Authors
A Hoque;D Albanes;SM Lippman;MR Spitz;PR Taylor;EA Klein;IM Thompson;P Goodman;JL Stanford;JJ Crowley;CA Coltman;RM Santella
Journal / Conference
Cancer Causes and Control 12:627-633
Year
2001
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The prostate cancer prevention trial: current status and lessons learned

Authors
IM Thompson;M Kouril;EA Klein;CA Coltman;A Ryan;P Goodman
Journal / Conference
Urology 57(Suppl.4A):230-234
Year
2001
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIb-III melanoma: results of Intergroup trial E1694/S9512/C509801

Authors
JM Kirkwood;JG Ibrahim;JA Sosman;VK Sondak;SS Agarwala;MS Ernstoff;U Rao
Journal / Conference
Journal of Clinical Oncology 19(9):2370-2380
Year
2001
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9512 (E1694)

Updated results of a prospective, randomized comparison of two doses of combination alkyating agents (AA) as consolidation after CAF in high-risk primary breast ca involving 10 or more axillary lymph nodes: CALGB 9082/SWOG 9114/NCIC Ma-13

Authors
WP Peters;G Rosner;J Vredenburgh;E Shpall;M Crump;L Marks;C Cirrincione;D Hurd;L Norton
Journal / Conference
Proc of the American Society of Clinical Oncology 20:21a(#81)
Year
2001
Research Committee(s)
Breast
Study Number(s)
SWOG-9114 (INT-0163) (CALGB-9082)